[1] 吴银亚,谭善忠. CD4+CD25+调节性T淋巴细胞在慢性乙型肝炎发病机制中的作用.中华传染病杂志,2012,30:563-565.
[2] 中华医学会肝病分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南.中华肝脏病杂志.2015,23:888-905.
[3] Lok AS, McMahon BJ, Practice Guidelines Committee. American Association for the Study of Liver Diseases(AASLD). Chronic hepatitis B: update of recommendations. Hepatology,2004,39:857-861.
[4] Stoop JN,van der Molen RG,Baan CC,et al.Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.Hepatology,2005,41:771-778.
[5] Baecher-Allan C, Viglietta V,Hafler DA. Inhibition of human CD4+CD25+highregulatory T cell function. J Immunol,2002,169:6210-6217.
[6] Sakaguchi S.Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol,2004,22:531-562.
[7] Lynch KW,Weiss A.A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer.J Biol Chem,2001,276:24341-24347.
[8] Woltman AM,van der Kooij SW,de Fijter JW,et al. Maturation resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CDRO+T-cell populations. Am J Transplant,2006,6:2580-2591.
[9] 施长友,张永乐. 慢性乙型肝炎患者T淋巴细胞亚群与自然杀伤细胞活性分析.中华医院感染学杂志,2012,22:4545-4547.
[10] 俞立飞,卢丹,张永乐,等. CD31分子在T淋巴细胞表面的表达频率和慢性HBV感染关系.中华实验和临床病毒学杂志,2016,30:499-502. |
